GT
ATHE

Greenleaf Trust’s Alterity Therapeutics ATHE Stock Holding History

Greenleaf Trust’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$111K Hold
32,000
– – ﹤0.01% 793
2025
Q4 		$98.6K Hold
32,000
– – ﹤0.01% 810
2025
Q3 		$120K Buy
32,000
+15,000
+88% +$72.4K ﹤0.01% 797
2025
Q2 		$69.5K Buy
+17,000
New +$66.7K ﹤0.01% 790

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Greenleaf Trust's ATHE Position: Q1 2026 in Review

Greenleaf Trust held its Alterity Therapeutics (ATHE) position steady in Q1 2026 at 32,000 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Greenleaf Trust first reported a position in ATHE in Q2 2025 and has held it in 4 quarters since. The position peaked at $120K in Q3 2025. 15 funds tracked by Wall St. Rank hold ATHE as of Q1 2026.

  • Greenleaf Trust held 32,000 shares of Alterity Therapeutics worth $111K as of Q1 2026.
  • Greenleaf Trust left its Alterity Therapeutics share count unchanged in Q1 2026.
  • Alterity Therapeutics made up ﹤0.01% of Greenleaf Trust's portfolio in Q1 2026, its #793 holding.
  • Greenleaf Trust first reported a position in Alterity Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Greenleaf Trust's Alterity Therapeutics position peaked at $120K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q1 2026.

Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.